ArticleRadiology case reports2025
Unexpected encounters: The surprising link between ovarian cancer and axillary lymphadenopathy.
Article in Radiology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ovarian tumors represent a significant health concern for women, often leading to morbidity and mortality. We present the case of a 46-year-old patient without notable personal or family history of tumors, who initially presented with bilateral axillary lymphadenopathy. Given the clinical presentation and suspicion of a Cancer of Unknown Primary (CUP) syndrome, the patient underwent imaging examination, such as ultrasound of the axilla, mammography, and breast magnetic resonance imaging. The axillary tru-cut biopsy histological examination revealed ovarian metastasis. The total body computed tomography (CT) scan and pelvic MRI confirmed the presence of a left ovarian tumor. The patient underwent surgical intervention with excision of the tumor and axillary lymph node dissection. Histological analysis confirmed the diagnosis of high-grade serous ovarian carcinoma. The patient was initiated on adjuvant chemotherapy and a long-term follow-up was scheduled. This case underscores the importance of comprehensive diagnostic evaluation in patients presenting with suspicious symptoms, such as axillary lymphadenopathy, to ensure timely and appropriate management of ovarian carcinoma and related conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.